The Ki-67-positivity rates and PCNA-average integrated optical densities were lower in the anlotinib group than in the positive control group, suggesting that tumor growth was inhibited in HNSCC PDX mice; moreover, anlotinib significantly inhibited tumor cell proliferation. The gene discussed is MKI67; the disease is head and neck squamous cell carcinoma.